COMPASS Pathways plc (CMPS)
USD 4.19
(2.2%)
USD 4.19
(2.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 50.24 Million USD | 213.74% |
| 2022 | 16.01 Million USD | -2.86% |
| 2021 | 16.48 Million USD | 139.1% |
| 2020 | 6.89 Million USD | -89.02% |
| 2019 | 62.77 Million USD | 54.04% |
| 2018 | 40.75 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 52.26 Million USD | 4.87% |
| 2024 Q1 | 49.83 Million USD | -0.82% |
| 2024 Q3 | 54.3 Million USD | 3.92% |
| 2023 Q2 | 43.43 Million USD | 272.35% |
| 2023 FY | 50.24 Million USD | 213.74% |
| 2023 Q3 | 45.77 Million USD | 5.39% |
| 2023 Q4 | 50.24 Million USD | 9.75% |
| 2023 Q1 | 11.66 Million USD | -27.15% |
| 2022 Q3 | 29.95 Million USD | 113.21% |
| 2022 FY | 16.01 Million USD | -2.86% |
| 2022 Q2 | 14.05 Million USD | 12.2% |
| 2022 Q1 | 12.52 Million USD | -24.04% |
| 2022 Q4 | 16.01 Million USD | -46.55% |
| 2021 Q1 | 7.63 Million USD | 10.79% |
| 2021 Q3 | 9.32 Million USD | 19.51% |
| 2021 Q4 | 16.48 Million USD | 76.83% |
| 2021 Q2 | 7.8 Million USD | 2.12% |
| 2021 FY | 16.48 Million USD | 139.1% |
| 2020 Q2 | 121.93 Million USD | 400.76% |
| 2020 Q1 | 24.35 Million USD | -61.21% |
| 2020 FY | 6.89 Million USD | -89.02% |
| 2020 Q4 | 6.89 Million USD | 40.14% |
| 2020 Q3 | 4.92 Million USD | -95.97% |
| 2019 FY | 62.77 Million USD | 54.04% |
| 2019 Q4 | 62.77 Million USD | 0.0% |
| 2018 FY | 40.75 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 97.967% |
| Addus HomeCare Corporation | 317.73 Million USD | 84.187% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | 61.22% |
| Amedisys, Inc. | 940.38 Million USD | 94.657% |
| Astrana Health, Inc. | 522.59 Million USD | 90.386% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 97.153% |
| IMAC Holdings, Inc. | 1.89 Million USD | -2548.877% |
| biote Corp. | 191.84 Million USD | 73.81% |
| Cryo-Cell International, Inc. | 72.25 Million USD | 30.461% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | 75.601% |
| DocGo Inc. | 185.28 Million USD | 72.883% |
| The Ensign Group, Inc. | 2.68 Billion USD | 98.125% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 85.503% |
| InnovAge Holding Corp. | 247.85 Million USD | 79.729% |
| The Joint Corp. | 62.37 Million USD | 19.455% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 93.753% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -1218.312% |
| ModivCare Inc. | 1.61 Billion USD | 96.881% |
| NewGenIvf Group Limited | 1.24 Million USD | -3947.171% |
| Option Care Health, Inc. | 1.9 Billion USD | 97.365% |
| P3 Health Partners Inc. | 427.3 Million USD | 88.242% |
| P3 Health Partners Inc. | 427.3 Million USD | 88.242% |
| The Pennant Group, Inc. | 394.17 Million USD | 87.254% |
| Surgery Partners, Inc. | 3.65 Billion USD | 98.626% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -5420.772% |
| Talkspace, Inc. | 23.57 Million USD | -113.12% |
| Talkspace, Inc. | 23.57 Million USD | -113.12% |
| The Oncology Institute, Inc. | 162.39 Million USD | 69.061% |
| The Oncology Institute, Inc. | 162.39 Million USD | 69.061% |